Related Experiment Video
Updated: Jul 12, 2025
06:34
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
4.0K
Left Ventricular Non-compaction Cardiomyopathy: A Case Report and Literature Review.
Sherif Elkattawy1, Jesus Romero2, Kalpesh Shah1
1Cardiology Department, St. Joseph's University Medical Center, USA.
Journal of Community Hospital Internal Medicine Perspectives
|October 25, 2023
Summary
Left Ventricular Non-Compaction Cardiomyopathy (LVNC) is a rare heart muscle disorder diagnosed via cardiac imaging. Management mirrors Heart Failure with reduced Ejection Fraction (HFrEF), with added anticoagulation due to clot risk.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Myocardial Diseases
Background:
- Left Ventricular Non-Compaction Cardiomyopathy (LVNC) is a rare congenital heart defect.
- It involves abnormal development of the left ventricular myocardium, leading to a spongy appearance.
- Diagnosis relies heavily on advanced cardiac imaging techniques.
Observation:
- The study discusses a specific case of LVNC.
- Diagnostic criteria for LVNC vary between echocardiography and cardiac MRI.
- A key diagnostic principle involves comparing non-compacted to compacted myocardial tissue thickness.
Findings:
- LVNC diagnosis predominantly uses thoracic echocardiography, with cardiac MRI for inconclusive cases.
- Management strategies for LVNC are largely consistent with Heart Failure with reduced Ejection Fraction (HFrEF).
- Anticoagulation is a critical addition to LVNC management due to inherent thrombogenic risks.
Implications:
- This case highlights the diagnostic challenges and therapeutic considerations in LVNC.
- Understanding the diagnostic criteria is crucial for accurate identification.
- The findings underscore the importance of tailored management, including anticoagulation, for improved patient outcomes in LVNC.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:25Cardiomyopathy I: Introduction and Classification
14
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
01:29Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13